Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
hubergroup’s two newly added medical vans are dedicated to dental and eye care
FedEx will be displaying a wide-range of effective healthcare packaging and specialized tracking technology
Women of all ages will get round-the-clock access to comprehensive treatment
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The audit is a pre-approval inspection for three products filed from the facility
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Subscribe To Our Newsletter & Stay Updated